Chelsea Bentow received her Bachelor of Science (BSc) degree in chemical engineering at the University of California, San Diego (UCSD) and has been working in the biotech industry for the last 9 years. In the past 6 years, Chelsea has worked in research for the development of new autoimmune diagnostic assays at Inova
Diagnostics. At the AMLI annual meeting in 2012, Chelsea was awarded the Young Investigator Award for her research project that developed a new method of detection for extractable nuclear antigens as a diagnostic tool for systemic autoimmune rheumatic diseases. Chelsea’s contributions to research has resulted in several published journal articles focused in improved diagnostic aids and novel biomarkers for autoimmune diseases including connective tissue disease, rheumatoid arthritis, and inflammatory bowel disease. In the last several years, Chelsea has attended and presented talks and posters at various scientific congresses globally. In her current role, Chelsea is leading a research team in the area of biomarker discovery and clinical affairs where they collaborate with prominent institutions, universities, and key opinion leaders worldwide to learn more about these diseases and ultimately provide better patient care.